PDA Technical Report No. 54-2(TR 54-2) Implementation of Quality Risk Management for Pharmaceutical & Biotechnology Manufacturing Operation:Annex 1: Case Study Examples for Quality Risk Management in Packaging & Labeling (single user digital version)
Premium Members: to claim your annual free technical document download, email [email protected] and indicate the document you wish to claim.
- Format
- PDF Single user
- Member Price
- $180.00
- Nonmember Price
- $325.00
- Government Price
- $180.00
Please sign in or become a member to purchase items from the PDA bookstore.
The first Annex to Technical Report No. 54: Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations provides specific case studies on how to apply quality risk management (QRM) to pharmaceutical manufacturing, specifically packaging and labeling operations.
This report is intended to align with ICH Q9 and is one in a series of similar documents that provide additional examples of how to apply risk management tools across the product supply chain.
Technical Report No. 54-2 was drafted by an all-volunteer team of experts representing companies like Merck, Amgen and Genentech.
Available to download
Format: PDF (1 file 1.52 MB)
Click here to view the digital downloading instruction and Terms of Usage
*To purchase licensing, please contact PDA at [email protected].
Click here to order paper ship version (Item no. 01054.2)
Table of Contents
Table of Contents:
Click here to download >>> Detailed Table of Contents- Introduction
- Glossary of Terms
- Case Study 1: Control of Liquid Drug Product During Packaging
- Case Study 2: Risks Associated with Secondary Packaging Components Production
- Case Study 3: Control of Logistics Channels for Liquid Product in Bulk Hold Pending Packaging
- Case Study 4: Risks in Packaging, Handling and Transport of Liquid Filled Glass Syringe
- Case Study 5: Control of Logistics Channels for Refrigerated Bulk Solid Oral Dose
- Conclusion
- Additional Reading
- References
About the Authors
Ghada Haddad, MBA, Chair Genentech/Merck
Mike Boyson, Millennium: The Takeda Oncology Company
Boriana Cavicchia, URS
Mary Foster, PharmD, Aphena Pharma Solutions
Mark Frankcom, Yellowscape Consulting
Martin Hunter, Amgen
Bill Leung, Genentech
Liza Munda, Genentech
Mindy Pang, Merck
James Robinson, Lachman Consultants
David Thatcher, Amgen